The table below shows Adaptive Biotechnologies Corp's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$70.87M
$93.97M
$58.88M
$52.44M
$46.44M
$43.19M
Cost of revenue
$18.71M
$18.16M
$18.00M
$16.98M
$16.67M
$19.32M
Gross profit
-
-
-
-
-
-
R&D
$23.62M
$23.67M
$24.13M
$24.20M
$24.16M
$25.35M
ADPT annual revenue (10-K history)
Adaptive Biotechnologies Corp reported annual revenue of $276.98M for fiscal year 2025. That is up 54.8% from $178.96M in fiscal 2024. Over the 9 fiscal years shown, annual revenue grew from $38.45M (FY 2017) to $276.98M. Figures come from the company's audited annual reports as filed with the SEC.
